Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-036275

VP Clinical Reg Affairs bought 800 shares at $13.85 ($11,080)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Jaye VP Clinical Reg Affairs 2024-08-12 Purchase +800 $13.85 $11,080 263,148 D
Open-market purchases · 800 sh · avg $13.85 · $11,080
Loading xslF345X05/ownership.xml…